Healthcare settings and clinical laboratories use blood gas analyzers to measure partial pressure of oxygen in a patient's body whereas electrolyte analyzers are used to measure the concentration of vital elements such as sodium, potassium, and calcium. According to a recent report from Market.biz, the global and regional Blood Gas Analyzer/Blood Gas and Electrolyte Analyzer market that is valued at USD 530.7 Million in 2017 is expected to grow at USD 699.1 Million by the end of 2023. The market is estimated to register a CAGR of 4.70% during the forecast period 2017-2023.
The increasing interest for this market showcase from colossal ventures, new businesses, and end-client shoppers has stirred the development of the Blood Gas Analyzer/Blood Gas and Electrolyte Analyzer industry over recent years.
The report divides the market on the basis of manufacturers, regions, type and application.
Key manufacturers mentioned in the report include ERBA Diagnostics Mannheim GmbH, Nova Biomedical, Roche Diagnostics Limited, Abbott Laboratories Inc, Radiometer Medical Aps (A Subsidiary of Danaher Corporation), Medica Corporation , Instrumentation Laboratory (A Werfen Company), OPTI Medical Systems Inc (A Subsidiary of Idexx Laboratories Inc) and Siemens AG.
End users of this market are mainly hospitals and diagnostic centers. Geographically, Asia-Pacific will hold the better position to hoist with CAGR of 4.70% with figure period from 2018 to 2023, while Europe recorded humble surge in the worldwide market over recent years with the second position. Other regions that contribute a superior offer of this industry include North America, Latin America, The Center East and Africa.
Types of analyzers include Cobas (Roche Diagnostics) analyzer, EPOC (Alere, GEM Premier (Instrumentation Laboratory), ABL Flex (Radiometer), and I-Stat (Abbott Laboratories).